Allied Market Research


Biologic Therapeutics Drugs Market

Biologic Therapeutics Drugs Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, by Application and by Source : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.

The major factors that contribute to the growth of the biologic therapeutic drugs market include increase in the prevalence of chronic diseases such as cancer, diabetes, & coronary artery diseases and a rise in geriatric population. Moreover, a large number of clinical trials and innovative R&D approaches to develop advanced drugs drive the market growth.

However, manufacturing difficulties due to the complexity of drug molecules hinder the market growth. Increase in R&D activities in the field of pharmaceutical industries and rise in therapeutical applications are anticipated to provide new opportunities for the market.

The biologic therapeutics drugs market is segmented on the basis of product, application, source, and region. Based on product, the market is bifurcated into vaccines, blood & blood products, allergenic extracts, human cells & tissues, gene therapies, protein, cellular therapies, and xenotransplantation products. By application, it is categorized into rheumatoid arthritis, anemia, cancer, diabetes, and others. In terms of source, it is classified into humans, avian cell culture, yeast, bacteria, insect cell culture, and xenotransplantation products. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the biologic therapeutics drugs market with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report offers a quantitative analysis to assist stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of different segments helps determine various products available in the market.
  • Key players have been profiled and their strategies thoroughly analyzed to predict the competitive market outlook.


Biologic Therapeutics Drugs Market Report Highlights

Aspects Details
By Product
  • Vaccines
  • Blood and Blood Products
  • Allergenic Extracts
  • Human Cells and Tissues
  • Gene Therapies
  • Proteins
  • Cellular Therapies
  • Xenotransplantation Products
By Application
  • Rheumatoid Arthritis
  • Anemia
  • Cancer
  • Diabetes
  • Others
By Source
  • Humans
  • Avian Cell Culture
  • Yeast
  • Bacteria
  • Insects Cell Culture
  • Transgenics
By Region
  • North America 
  • Europe 
  • Asia-Pacific 
  • LAMEA 
Key Market Players

AstraZeneca, Merck & Co. Inc., Smith Medical, H. Lundbeck A/S, GlaxoSmithKline Plc., Concord Biotech, Pfizer Inc., Retractable Technologies, Inc., Novartis Global, Aurobindo Pharma Ltd.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Biologic Therapeutics Drugs Market

Global Opportunity Analysis and Industry Forecast, 2023-2032